Market revenue in 2023 | USD 19.1 million |
Market revenue in 2030 | USD 41.8 million |
Growth rate | 11.8% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 60.21% in 2023. Horizon Databook has segmented the Australia pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical sterility testing market in Australia is anticipated to grow gradually over the forecast period due to superior clinical research, advanced healthcare infrastructure, improved research capabilities, and the availability of highly skilled researchers.
In June 2023, the Medical Research Future Fund (MRFF) of the Commonwealth Government allocated USD 9.75 million to inaugurate MedChem Australia, a novel national initiative focused on medicinal chemistry.
MedChem Australia is set to unite three prominent medical chemistry groups in the country, namely the University of Sydney, Monash University, and the Walter & Eliza Hall Institute of Medical Research (WEHI). The government is also committed to supporting and improving the clinical trial environment, as evidenced by substantial investment.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Australia pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account